Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease (Q38722255)

5 September 2017

1 reference

title

Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease (English)

1 reference

5 September 2017

Junjun Zhao

1

1 reference

5 September 2017

Shuqing Yu

2

1 reference

5 September 2017

Yan Zheng

3

1 reference

5 September 2017

Hui Yang

4

1 reference

5 September 2017

Jianliang Zhang

5

1 reference

5 September 2017

language of work or name

1 reference

3 February 2016

1 reference

5 September 2017

published in

Molecular Neurobiology

1 reference

5 September 2017

volume

54

1 reference

5 September 2017

issue

2

1 reference

5 September 2017

page(s)

1404-1418

1 reference

Depression, intellectual impairment, and Parkinson disease.

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Biomedicine. Parkinson's--divergent causes, convergent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Locus-specific mutation databases for neurodegenerative brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Epidemiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

mtDNA Mutations and Their Role in Aging, Diseases and Forensic Sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The ubiquitin pathway in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Mitochondria and dopamine: new insights into recessive parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Mitochondrial association of alpha-synuclein causes oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The role of oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Lipopolysaccharide animal models for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Aging: a theory based on free radical and radiation chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Quantitative analysis of glutathione in rat central nervous system: comparison of GSH in infant brain with that in adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Redox systems of the cell: possible links and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Redefining oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Glutathione metabolism and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Microglial cell dysregulation in brain aging and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Multiple factors from bradykinin-challenged astrocytes contribute to the neuronal apoptosis: involvement of astroglial ROS, MMP-9, and HO-1/CO system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Oxidative and nitrative protein modifications in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Oxidative and other posttranslational modifications in extracellular vesicle biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

NOX2 complex-derived ROS as immune regulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Mitochondrial formation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Role of reactive oxygen species-mediated signaling in aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Beyond oxidative stress: an immunologist's guide to reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Free radicals in the physiological control of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The cell cycle is a redox cycle: linking phase-specific targets to cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Reactive oxygen species mediate crosstalk between NF-kappaB and JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Role of Oxidative RNA Damage in Chronic-Degenerative Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Oxidized messenger RNA induces translation errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

RNA molecules stimulate prion protein conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in APC(Min/+) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Preferential targeting of oxidative base damage to internucleosomal DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Intracellular generation of reactive oxygen species by mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The role of mitochondrial DNA mutations and free radicals in disease and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Oxidative stress, mitochondria and mtDNA-mutator mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Roles of PCNA-binding and ubiquitin-binding domains in human DNA polymerase eta in translesion DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The hMsh2-hMsh6 complex acts in concert with monoubiquitinated PCNA and Pol η in response to oxidative DNA damage in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Reversible inactivation of deubiquitinases by reactive oxygen species in vitro and in cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Starting and stopping SUMOylation. What regulates the regulator?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

SUMO: regulating the regulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

SUMO: a history of modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Role of SUMO modification of human PCNA at stalled replication fork

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Protein homeostasis and aging in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Methionine oxidation, alpha-synuclein and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Modulation of alpha-synuclein aggregation by dopamine: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Dopamine quinones interact with alpha-synuclein to form unstructured adducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Converse modulation of toxic alpha-synuclein oligomers in living cells by N'-benzylidene-benzohydrazide derivates and ferric iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Generation of ferric iron links oxidative stress to α-synuclein oligomer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Degradation of oxidized proteins by the 20S proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Protein oxidation and proteolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Regulation of the 26S proteasome complex during oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Redox control of 20S proteasome gating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Reversible 26S proteasome disassembly upon mitochondrial stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Dopamine midbrain neurons in health and Parkinson's disease: emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Mitochondrial reactive oxygen species inactivate neuronal nicotinic acetylcholine receptors and induce long-term depression of fast nicotinic synaptic transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The open pore conformation of potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Gating mechanism of KATP channels: function fits form

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Concerted gating mechanism underlying KATP channel inhibition by ATP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Neuroprotective role of ATP-sensitive potassium channels in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

AMPA receptor-dependent H2O2 generation in striatal medium spiny neurons but not dopamine axons: one source of a retrograde signal that can inhibit dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

A view of sur/KIR6.X, KATP channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The structure and function of the ATP-sensitive K+ channel in insulin-secreting pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Physiological and pathophysiological roles of ATP-sensitive K+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Advances in environmental epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Pharmacological chaperoning of nAChRs: a therapeutic target for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Nicotine-modulated subunit stoichiometry affects stability and trafficking of α3β4 nicotinic receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Reactive oxygen species inactivate neuronal nicotinic acetylcholine receptors through a highly conserved cysteine near the intracellular mouth of the channel: implications for diseases that involve oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Nicotinic acetylcholine receptors and the regulation of neuronal signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Diabetes depresses synaptic transmission in sympathetic ganglia by inactivating nAChRs through a conserved intracellular cysteine residue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Nicotine as a potential neuroprotective agent for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

The Role of Cysteine Oxidation in DJ-1 Function and Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Neuroprotective function of DJ-1 in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Increase of oxidative stress by a novel PINK1 mutation, P209A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down-regulation of pAkt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9743-3

Interaction of reactive oxygen species with ion transport mechanisms.

21 January 2018

1 reference

12 December 2020

Regulation of ubiquitin-dependent processes by deubiquitinating enzymes

1 reference

12 December 2020

The generation of natural firing patterns in neostriatal neurons

1 reference

12 December 2020

Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation

1 reference

12 December 2020

Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice

1 reference

12 December 2020

Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2.

1 reference

12 December 2020

Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain

1 reference

12 December 2020

Protein mobility and GABA-induced conformational changes in GABA(A) receptor pore-lining M2 segment

1 reference

12 December 2020

10.1007/S12035-016-9743-3

Identifiers

DOI

1 reference

Dimensions Publication ID

5 September 2017

1033989843

0 references

1 reference